EFFICACY AND TOLERABILITY OF NEBIVOLOL COMPARED WITH OTHER ANTIHYPERTENSIVE DRUGS: A META-ANALYSIS

Aim: Lowering BP to normal levels without quality of life deterioration is the most important means of reducing cardiovascular risk. Recent studies have challenged the position of beta-adrenoreceptor antagonists (beta-blockers) as first-line antihypertensive drugs. Nebivolol is a third-generation, h...

Full description

Bibliographic Details
Main Authors: L. M. Van Bortel, Francesco Fici, Flavio Mascagni
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2011-02-01
Series:Российский кардиологический журнал
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1091